R2 Technologies, a portfolio company of INNOVATE Corp., announced several impressive milestones during 2024, including a 294% increase in worldwide Glacial Skin system unit sales over the same period last year. This growth follows the one-year anniversary of the Glacial fx platform launch, demonstrating strong market adoption for its CryoAesthetics solutions.
The company has forged significant new partnerships, including an agreement with Woodhouse Spas, one of the country's leading luxury spa brands with nearly 100 locations nationwide. Additionally, R2 has established protocols with several leading skincare brands such as Epicutis, iS CLINICAL, BABOR, and BioSkin Aesthetics, enhancing the personalization of its Glacial Skin offerings.
Operational metrics also showed substantial improvement, with providers using Glacial Skin systems experiencing a 168% increase in patients treated and a 58% increase in average monthly utilization per provider compared to the previous year. R2 Technologies further expanded its capabilities by launching a colder version of the Glacial Glide Rx protocol, broadening its treatment range for skin inflammation. The company also reported an astonishing 4,086% increase in social media mentions in Q3, amplifying brand awareness and driving continued momentum.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.